Assignee
NSABP FOUNDATION INC
US·1 granted patent·8 pending applications·148 citations·filing 2004–2014
Top patents by PatentIndex Score
9 records- 0195US7056674B2Prediction of likelihood of cancer recurrenceNSABP FOUNDATION INC·Filed 2004·Granted Jun 6, 2006·148 cites·10 claims
- 0261US2009304697A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2009·Application pending·0 cites
- 0357US2006127935A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2005·Application pending·0 cites
- 0456US2014206545A1Gene expression markers for prediction of patient response to chemotherapyNSABP FOUNDATION INC·Filed 2013·Application pending·0 cites
- 0555US2009035311A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2008·Application pending·0 cites
- 0643US2014348821A1Defective Mismatch Repair and Benefit from Bevacizumab for Colon CancerNSABP FOUNDATION INC·Filed 2014·Application pending·0 cites
- 0742US2007254305A1Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissueNSABP FOUNDATION INC·Filed 2007·Application pending·0 cites
- 0840US2013251710A1Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesNSABP FOUNDATION INC·Filed 2013·Application pending·0 cites
- 0932US2011262434A1Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesNSABP FOUNDATION INC·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →